[
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-1",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#definitiongeneral382878",
    "clean_content": "Definition / general\n\n* Carcinoma of the pancreas that does not show a definitive direction of differentiation* Under this definition, there are 4 variants: anaplastic, sarcomatoid, rhabdoid and carcinosarcoma ([Mod Pathol 2015;28:248](25103069))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-2",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#essentialfeatures382879",
    "clean_content": "Essential features\n\n* Undifferentiated carcinoma with atypical neoplastic cells and without gland formation* Absence of osteoclast-like giant cells* Very poor prognosis"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-3",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#terminology382880",
    "clean_content": "Terminology\n\n* Undifferentiated carcinoma of the pancreas* Old terminology, not in use: spindle cell carcinoma, pleomorphic carcinoma"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-4",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#icdcoding382881",
    "clean_content": "ICD coding\n\n* ICD-O:\n  + [8020/3](https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf#page=62) - carcinoma, undifferentiated, NOS+ [8021/3](https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf#page=62) - carcinoma, anaplastic, NOS* ICD-10:\n    + [C25.9](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C15-C26/C25-/C25.9) - malignant neoplasm of pancreas, unspecified"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-5",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#epidemiology382882",
    "clean_content": "Epidemiology\n\n* M:F = 2:1 ([World J Gastroenterol 2016;22:8631](27784976))* Commonly presents in the sixth to seventh decades ([World J Gastroenterol 2016;22:8631](27784976), [J Am Coll Surg 2012;215:627](23084492))* 1 - 5% of all pancreatic cancers ([World J Gastroenterol 2016;22:8631](27784976), [J Am Coll Surg 2012;215:627](23084492))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-6",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#sites382883",
    "clean_content": "Sites\n\n* Head of the pancreas (50% of cases), body / tail (45%), entire pancreas (5%) ([World J Gastroenterol 2016;22:8631](27784976))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-7",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#pathophysiology382884",
    "clean_content": "Pathophysiology\n\n* The process of epithelial to mesenchymal transition may play an important role ([Pancreas 2019;48:36](30451796), [Virchows Arch 2021;478:319](32661742))* Chronic inflammation with histiocytes is not a crucial mechanism as in undifferentiated carcinoma with osteoclast-like giant cells ([Hum Pathol 2018;81:157](30031096))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-8",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#clinicalfeatures382887",
    "clean_content": "Clinical features\n\n* Presenting symptoms include jaundice (tumors in the pancreatic head), abdominal or back pain, weight loss, nausea and anemia ([Diagn Cytopathol 2016;44:538](27028547), [World J Gastroenterol 2016;22:8631](27784976), [World J Clin Cases 2019;7:236](30705901))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-9",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#diagnosis382888",
    "clean_content": "Diagnosis\n\n* CT scan and MRI are the preferred imaging modality ([J Med Imaging Radiat Oncol 2019;63:580](31268241))* Diagnosis is by biopsy or surgical resection"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-10",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#radiologydescription382890",
    "clean_content": "Radiology description\n\n* Usually mass lesions with delayed enhancement, intratumor calcifications ([J Med Imaging Radiat Oncol 2019;63:580](31268241))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-11",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#prognosticfactors382892",
    "clean_content": "Prognostic factors\n\n* Prognosis is very poor, with an average survival time of just 5 months, making it difficult to describe significant prognostic factors ([J Am Coll Surg 2012;215:627](23084492))* Absence of osteoclast-like giant cells is important for the diagnosis of real, undifferentiated carcinoma (i.e., to avoid misdiagnosis) but is essential for the prognosis as well, since the prognosis of real, undifferentiated carcinoma is very poor, compared with that of carcinoma with osteoclast-like giant cells"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-12",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#casereports382893",
    "clean_content": "Case reports\n\n* 59 year old man with undifferentiated carcinoma of the pancreas, sarcomatoid type ([World J Clin Cases 2019;7:236](30705901))* 63 year old man with undifferentiated carcinoma of the pancreas, rhabdoid type, with multiple metastases (autopsy report) ([Pathol Int 2015;65:264](25753521))* 64 year old woman with undifferentiated carcinoma of the pancreas, anaplastic type, associated with cystic degeneration of the lesion ([World J Gastroenterol 2016;22:8631](27784976))* 65 year old man with undifferentiated carcinoma of the pancreas, anaplastic type, involving the ampullary region ([Am J Case Rep 2019;20:597](31023997))* 73 year old woman with undifferentiated carcinoma of the pancreas, carcinosarcoma type ([Pancreas 2017;46:1225](28902796))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-13",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#treatment382894",
    "clean_content": "Treatment\n\n* Surgical resection if possible; gemcitabine based chemotherapy / radiotherapy ([J Surg Res 2017;219:238](29078888))* A recent study highlighted a possible role of immunotherapy in selected cases, PDL1 positive ([Expert Opin Ther Targets 2021;25:1007](34846251))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-14",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#grossdescription382896",
    "clean_content": "Gross description\n\n* Very often similar to conventional pancreatic ductal adenocarcinoma* May show cystic degeneration and necrosis ([World J Gastroenterol 2016;22:8631](27784976))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-15",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#grossimages382897",
    "clean_content": "Gross images\n\nContributed by Claudio Luchini, M.D., Ph.D. and AFIP  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini01.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini01.jpg)\n\nDuctal   \nadenocarcinoma  \n with undifferentiated   \ncomponent\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_075T.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_075T.jpg)\n\nIll demarcated tumor in head of pancreas\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_075B.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_075B.jpg)\n\nExtensive hemorrhagic necrosis"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-16",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Frozen section description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#frozensectiondescription382898",
    "clean_content": "Frozen section description\n\n* Hypercellular neoplasm with atypical cells"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-17",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#microscopichistologicdescription382900",
    "clean_content": "Microscopic (histologic) description\n\n* Unlike conventional ductal adenocarcinoma, this tumor is composed of poorly cohesive cells* Undifferentiated carcinoma of the pancreas is a hypercellular tumor with scant stroma and scant desmoplastic reaction; this differs from conventional pancreatic ductal adenocarcinoma which has a large amount of desmoplastic stroma with few neoplastic cells / glands\n    + This is a major point in the differential diagnosis between these 2 entities* Perineural invasion and vascular invasion are very common* Different subtypes are characterized at the histological level by different morphologic hallmarks:\n        + Anaplastic subtype is a tumor composed of > 80% highly atypical cells that have pleomorphic nuclei and lack gland formation+ Sarcomatoid subtype is composed of > 80% atypical spindle cells, resembling a sarcoma ([Int J Mol Sci 2022;23:1283](35163206), [Hum Pathol 2022;128:124](35850360))\n            - Rhabdoid subtype is a very rare sarcomatoid variant which is composed of large atypical cells with eosinophilic cytoplasm and eccentrically located nuclei+ Carcinosarcoma is a subtype in which there is a mixture of roundish epithelioid cells and spindle sarcomatous cells; each component should arbitrarily constitute 30% of the neoplasm to qualify as carcinosarcoma"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-18",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#microscopichistologicimages382901",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Claudio Luchini, M.D., Ph.D. and AFIP  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini02.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini02.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini03.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini03.jpg)\n\nAnaplastic undifferentiated carcinoma\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini04.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini04.jpg)\n\nMassive perineural invasion\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini05.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini05.jpg)\n\nMassive vascular invasion\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini06.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini06.jpg)\n\nAssociation with ductal adenocarcinoma\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini07.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini07.jpg)\n\nInvasion of duodenum\n\n  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini08.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini08.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini09.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini09.jpg)\n\nRhabdoid aspects\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini010.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini010.jpg)\n\nBiopsy\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini011.jpg)](https://www.pathologyoutlines.com/imgau/pancreasundifferentiatedLuchini011.jpg)\n\nDetails on biopsy\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_078T.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_078T.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_078B.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_078B.jpg)\n\nSpindle cell sarcomatoid features\n\n  \n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_076.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_076.jpg)\n\nPleomorphic large cells\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_077.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_077.jpg)\n\nEngulfment of red blood cells\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_079.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_079.jpg)\n\nGlandular differentiation\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_080.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_080.jpg)\n\nTumor is keratin+\n\n[![Missing Image](https://www.pathologyoutlines.com/images/pancreas/4_081.jpg)](https://www.pathologyoutlines.com/images/pancreas/4_081.jpg)\n\nTumor is CEA+ in glandular portions"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-19",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#cytologydescription382903",
    "clean_content": "Cytology description\n\n* Hypercellular neoplasm: presence of highly atypical cells"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-20",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#positivestains382907",
    "clean_content": "Positive stains\n\n* [Vimentin](https://www.pathologyoutlines.com/topic/stainsvimentin.html) and [keratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html)"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-21",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#negativestains382908",
    "clean_content": "Negative stains\n\n* Neoplastic cells are negative for [E-cadherin](https://www.pathologyoutlines.com/topic/stainsecadherin.html)* ~50% of undifferentiated rhabdoid carcinomas typically present a nuclear loss of [SMARCB1 / INI1](https://www.pathologyoutlines.com/topic/stainsini1.html) at immunohistochemistry ([J Gastrointest Oncol 2021;12:874](34012674), [Mod Pathol 2015;28:248](25103069))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-22",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#molecularcytogeneticsdescription382911",
    "clean_content": "Molecular / cytogenetics description\n\n* Overlaps with the genetic profile of conventional ductal adenocarcinoma* In the rhabdoid variant, *KRAS* alterations and *SMARCB1* expression status define 2 subtypes, with possible translational implications ([Mod Pathol 2015;28:248](25103069))* There is an enrichment in *KRAS* amplification in both rhabdoid and sarcomatoid variants, if compared with conventional ductal adenocarcinoma ([Mod Pathol 2015;28:248](25103069), [Hum Pathol 2022;128:124](35850360))* *SMAD4* alterations appear as a rare molecular event in the sarcomatoid variant, if compared with conventional ductal adenocarcinoma ([Hum Pathol 2022;128:124](35850360))"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-23",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#samplepathologyreport382914",
    "clean_content": "Sample pathology report\n\n* Pancreas, pancreatectomy:\n  + Pancreatic undifferentiated carcinoma* Pancreas, biopsy / cytology:\n    + Pancreatic undifferentiated carcinoma (see comment)+ Comment: Cellular neoplasm with highly atypical cells is consistent with undifferentiated carcinoma of the pancreas.+ Surgical resection: percentage of the undifferentiated component; infiltration, if any, of duodenum, common bile duct, neck margin, intestinal margin and retroperitoneal margin if Whipple resection, spleen and pancreatic margin if distal pancreatectomy; vascular / perineural invasion if any; nodal metastasis (if any); pTNM staging."
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-24",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#differentialdiagnosis382915",
    "clean_content": "Differential diagnosis\n\n* [Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells](https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html):\n  + Presence of osteoclast-like giant cells* **Sarcoma**:\n    + [Keratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html) is negative* [Melanoma](https://www.pathologyoutlines.com/topic/skintumormelanocyticmelanoma.html):\n      + Melanoma is [S100](https://www.pathologyoutlines.com/topic/stainss100.html)+ contains melanin pigment, whereas undifferentiated carcinoma of the pancreas is [S100](https://www.pathologyoutlines.com/topic/stainss100.html)-"
  },
  {
    "id": "undifferentiated-carcinoma_42195_1750166975.txt-25",
    "source_document": "undifferentiated-carcinoma_42195_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html#additionalreferences382916",
    "clean_content": "Additional references\n\n* [WHO Classification of Tumours Editorial Board: Digestive System Tumours, 5th Edition, 2019](https://www.amazon.com/exec/obidos/ASIN/9283244990/pathologyoutl-20)"
  }
]